South America Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Devices, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others)-Forecast to 2035

South America Percutaneous Coronary Intervention Market Overview

As per MRFR analysis, the South America Percutaneous Coronary Intervention Market Size was estimated at 850.68 (USD Million) in 2023.The South America Percutaneous Coronary Intervention Market is expected to grow from 936.0(USD Million) in 2024 to 2,678.0 (USD Million) by 2035. The South America Percutaneous Coronary Intervention Market CAGR (growth rate) is expected to be around 10.028% during the forecast period (2025-2035).

Key South America Percutaneous Coronary Intervention Market Trends Highlighted

The market for percutaneous coronary intervention in South America is expanding significantly due to a number of important factors. The desire for novel treatment options is mostly being influenced by the rising prevalence of cardiovascular disorders in the area.

Cardiovascular problems are emerging as one of the main causes of morbidity and death, according to health reports from several South American nations. Percutaneous coronary interventions (PCI) are becoming more popular as a result of increased accessibility to healthcare facilities and increased awareness of modern medical techniques.

Regarding chances to be investigated, regional healthcare technology companies have a significant chance to create affordable solutions that are suited to the particular requirements of South American communities.

Increasing collaborations between public and commercial sectors might encourage PCI technology innovation and enhance patient outcomes overall. Furthermore, the region's developing markets offer a favorable environment for the introduction of novel tools and methods that may improve procedure outcomes and patient care.

Recent trends indicate a rise in the use of minimally invasive PCI procedures, which is bolstered by new developments in medical technology. There is a noticeable trend toward the use of drug-eluting stents and sophisticated imaging technologies to increase procedural safety and accuracy as South American healthcare institutions strive for modernization.

Additionally, educational programs aimed at teaching medical practitioners cutting-edge PCI techniques are becoming more popular, which should raise the standard of care in many nations.

All things considered, the South American percutaneous coronary intervention market is about to enter a revolutionary stage that will be marked by creativity, teamwork, and an increasing emphasis on patient-centered medical care.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

South America Percutaneous Coronary Intervention Market Drivers

Increase in Cardiovascular Diseases

The prevalence of cardiovascular diseases (CVD) in South America is a significant driver for the South America Percutaneous Coronary Intervention Market. According to the Pan American Health Organization, CVD accounts for over 30% of total deaths in the region, indicating a persistent need for advanced cardiovascular treatments.

Additionally, Brazil reports an increase in coronary artery disease incidences by approximately 15% over the last five years. The government and healthcare organizations are investing in healthcare infrastructure and awareness campaigns, catalyzing demand for PCI procedures.

Major health organizations, like the Brazilian Society of Cardiology, promote the adoption of innovative interventional treatments, bolstering market growth. This increasing CVD prevalence and healthcare push results in heightened demand for percutaneous coronary interventions across South America.

Technological Advancements in PCI Equipment

The evolution and enhancement of PCI technologies are pivotal drivers of the South America Percutaneous Coronary Intervention Market. Recent technological innovations have improved the efficacy and safety of PCI procedures, leading to an increase in patient referrals for these treatments.

For instance, the introduction of drug-eluting stents has transformed the landscape of coronary interventions. Data from the Argentinian Ministry of Health shows a 25% rise in successful PCI procedures directly linked to these advancements over the past four years.

Furthermore, regional distributors like Intervencao Cardio are actively collaborating with global manufacturers to supply cutting-edge devices, further amplifying market growth opportunities in South America.

Growing Aging Population

The demographic shift towards an aging population in South America is a crucial market driver for the South America Percutaneous Coronary Intervention Market. The World Health Organization predicts that individuals aged 60 and older will account for approximately 20% of South America's population by 2030.

This demographic transition is associated with higher rates of chronic diseases, including cardiovascular conditions necessitating percutaneous interventions. Countries like Chile, with significant percentages of senior citizens, are increasingly focused on upgrading healthcare facilities and expanding access to PCI surgeries.

Initiatives led by regional health ministries underscore the urgency in addressing the healthcare demands of an aging populace, resulting in amplifying pressures on the healthcare systems to provide adequate PCI services.

South America Percutaneous Coronary Intervention Market Segment Insights

Percutaneous Coronary Intervention Market Product Type Insights

The South America Percutaneous Coronary Intervention Market is characterized by a diverse range of product types that play a critical role in managing cardiovascular diseases. Among these, Coronary Stents have shown significant advancements, offering enhanced patency rates and reduced restenosis risk, thereby becoming a cornerstone in treating coronary artery disease.

These devices are complemented by Balloon Catheters, which are essential for the expansion of narrowed arteries during angioplasty procedures, making them integral to PCI success. Moreover, Coronary Guidewires and Guiding Catheters are pivotal in providing the necessary support and navigation during interventional procedures, thereby facilitating minimally invasive techniques.

Additionally, products such as Guiding Sheaths enhance the overall efficacy of procedures by allowing easier introduction and stabilization of other devices, thereby improving procedural efficiency. Diagnostic Catheters are vital for obtaining accurate imaging and diagnostics of coronary arteries, which aids in treatment planning.

Crossing Catheters, utilized for navigating blocked vessels, has also gained prominence in complex cases. Other key devices, such as Inflation Devices and Guidance Systems, not only improve procedural outcomes but also enhance the safety profiles of interventions.

In terms of evolving market dynamics, the Peripheral Thrombectomy Systems and Embolic Protection Systems are increasingly being integrated into the PCI landscape, focusing on preventing complications during procedures. Accessories play supportive roles that are essential for maximizing the functionality and effectiveness of primary devices, thus enriching the procedural arsenal available to clinicians.

As the demand for effective cardiovascular treatments increases in South America, these product types collectively underscore the region's commitment to advancing cardiac care and improving patient outcomes in percutaneous interventions.

The market's growth is further driven by a rising patient population with cardiovascular diseases, increasing health awareness, and ongoing technological innovations that pave the way for improved procedural precision and safety across all product segments within the South America Percutaneous Coronary Intervention Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Percutaneous Coronary Intervention Market Vascular Access Insights

The Vascular Access segment within the South America Percutaneous Coronary Intervention Market plays a crucial role in enabling effective coronary procedures. This segment consists of various methods, notably including Radial and Femoral approaches, that are essential for facilitating access to the coronary arteries.

The Radial approach has gained significant traction due to its lower complication rates and enhanced comfort for patients, making it a preferred choice among healthcare professionals in the region. In contrast, the Femoral approach still holds importance, particularly in complex cases where extensive intervention may be required.

The ongoing advancements in catheter and imaging technologies are driving trends in this segment, improving success rates and patient outcomes. Furthermore, there are increasing demands for minimally invasive procedures, which are supported by the capabilities offered through these vascular access methods.

The impact of regional demographics, including a rising elderly population and an increase in cardiovascular diseases, also underscores the need for efficient vascular access solutions in South America. As healthcare systems continue to evolve, the Vascular Access segment is poised for significant growth, reflecting broader trends in the South America Percutaneous Coronary Intervention Market.

Percutaneous Coronary Intervention Market End User Insights

The South America Percutaneous Coronary Intervention Market comprises a diverse array of End Users, with Hospitals Clinics, Ambulatory Surgical Centers, and Other facilities playing pivotal roles. Hospitals Clinics are integral to this market, as they offer comprehensive cardiac care and advanced technologies necessary for critical procedures.

The rise in cardiovascular diseases has driven demand in these settings, establishing them as key players. Ambulatory Surgical Centers are gaining prominence due to their efficiency and outpatient services, providing patients with convenient alternatives to traditional inpatient procedures.

This trend aligns with the healthcare shift towards more cost-effective care, appealing to both patients and insurers. Other types of facilities, including specialized cardiac centers, also contribute significantly to the landscape by providing tailored services and leveraging advanced intervention techniques.

The segmentation of the market reflects the variety of healthcare solutions available, with each End User type addressing specific patient needs and preferences, thus enhancing overall market dynamics in South America. As the region's healthcare infrastructure evolves, these settings will continue to adapt, driven by technological innovations and increasing patient awareness.

South America Percutaneous Coronary Intervention Market Key Players and Competitive Insights

The South America Percutaneous Coronary Intervention Market has shown promising growth due to increasing cardiovascular diseases, aging populations, and rising healthcare expenditures across the region. As interventional cardiology gains popularity among healthcare professionals, the competition among key players in this market has intensified.

Companies are focused on innovation, product development, and strategic collaborations to enhance their market presence and fulfill the growing demand for efficient and effective percutaneous coronary interventions.

Additionally, regional regulations and advancements in medical technologies are significant driving forces that influence competitive dynamics in this market. Understanding these competitive insights provides valuable context for assessing the market landscape and identifying opportunities for growth.

Terumo Corporation has established a strong foothold in the South America Percutaneous Coronary Intervention Market, driven by its commitment to quality and innovation. The company is recognized for its advanced catheter technology and reliable coronary devices that have become essential in interventional procedures.

Terumo Corporation focuses on the development of innovative products that cater to the specific needs of the South American healthcare sector, thus enhancing its competitive edge. With a robust distribution network and strategic partnerships within the region, the company has effectively penetrated key markets.

The strength of Terumo Corporation lies in its dedication to research and development, allowing it to continually introduce cutting-edge solutions to improve patient outcomes in percutaneous coronary interventions.

Johnson and Johnson plays a pivotal role in the South America Percutaneous Coronary Intervention Market, offering a diverse range of cardiovascular products and services tailored for local needs. The company is well-known for its comprehensive portfolio that includes stents, balloons, and delivery systems which are crucial for successful PCI procedures.

Johnson and Johnson has made significant investments aimed at expanding its footprint within the region, ensuring consistent availability of its advanced medical technologies. The strength of Johnson and Johnson lies in its strong brand recognition, extensive research capabilities, and a commitment to improving heart health.

Mergers and acquisitions have also been a core aspect of their growth strategy, enabling them to integrate innovative technologies and enhance their product offerings in the South American market. Consequently, Johnson and Johnson remains a formidable competitor in the dynamic landscape of percutaneous coronary interventions across South America.

Key Companies in the South America Percutaneous Coronary Intervention Market Include

• Terumo Corporation


• Johnson and Johnson


• Boston Scientific


• Siemens Healthineers


• Philips


• B. Braun Melsungen


• Cordis


• Asahi Intecc


• Abbott Laboratories


• Medtronic


• C. R. Bard


• Edwards Lifesciences


• Cardinal Health


• AngioDynamics


• Cook Medical

South America Percutaneous Coronary Intervention Market Developments

The South America Percutaneous Coronary Intervention Market has seen significant developments recently, driven by technological advancements and increased healthcare spending in the region. Notable market players such as Terumo Corporation, Johnson Johnson, and Boston Scientific are expanding their product offerings to meet growing demand.

In September 2023, Philips announced improvements in its cardiac imaging technologies aimed at optimizing PCI procedures in Brazil, reflecting a focus on innovation in the sector. Meanwhile, Medtronic has been actively promoting its newest coronary stents and delivery systems across multiple South American countries.

The market has also experienced growth, with estimates indicating that healthy competition and technological breakthroughs among major companies are projected to boost market valuation considerably in the coming years.

In terms of mergers and acquisitions, B. Braun Melsungen's acquisition of certain assets from a local competitor in August 2023 aims to strengthen their position in the region’s PCI landscape.

Furthermore, initiatives aimed at enhancing patient access to catheterization labs have been on the rise, with various governments prioritizing investments in health infrastructures in countries like Argentina and Colombia, thereby driving the market's evolution.

South America Percutaneous Coronary Intervention Market Segmentation Insights

• Percutaneous Coronary Intervention Market Product Type Outlook


• Coronary Stents


• Ballon Catheters


• Coronary Guidewires


• Guiding Catheters


• Guiding Sheaths


• Diagnostic Catheters


• Crossing Catheters


• Inflation Device


• Guidance System


• Peripheral Thrombectomy System


• Embolic Protection System


• Accessories


• Percutaneous Coronary Intervention Market Vascular Access Outlook


• Radial


• Femoral


• Percutaneous Coronary Intervention Market End User Outlook


• HospitalsClinics


• Ambulatory Surgical Centers


• Others

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	850.68(USD Million)
MARKET SIZE 2024	936.0(USD Million)
MARKET SIZE 2035	2678.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	10.028% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Terumo Corporation, Johnson and Johnson, Boston Scientific, Siemens Healthineers, Philips, B. Braun Melsungen, Cordis, Asahi Intecc, Abbott Laboratories, Medtronic, C. R. Bard, Edwards Lifesciences, Cardinal Health, AngioDynamics, Cook Medical
SEGMENTS COVERED	Product Type, Vascular Access, End User
KEY MARKET OPPORTUNITIES	Rising prevalence of cardiovascular diseases, Increasing healthcare investments and infrastructure, Growing demand for minimally invasive procedures, Advancements in catheter technology, Collaboration with local healthcare providers
KEY MARKET DYNAMICS	Growing prevalence of cardiovascular diseases, Increasing healthcare expenditure, Advancements in catheter technologies, Rising elderly population, Enhanced patient awareness and education
COUNTRIES COVERED	Brazil, Mexico, Argentina, Rest of South America